We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Centauri Therapeutics Ltd closes £2.5m fundraising

News   Feb 23, 2017 | Original Story From Centauri Therapeutics

 
Centauri Therapeutics Ltd closes £2.5m fundraising
 
 
Advertisement
 

RELATED ARTICLES

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Turning the Virus’ RBD Into a Nanoparticle an Appealing Approach for COVID-19 Vaccine

News

A University at Buffalo-led research team has discovered a technique that could help increase the effectiveness of vaccines against the novel coronavirus, the virus that causes COVID-19.

READ MORE

Deep Learning Model Helps Drug Developers Target SARS-CoV-2's Main Protease

News

Researchers have deployed a machine learning model to help drug developers on their most promising leads for attacking one of the virus’ most compelling targets –SARS-CoV-2's main protease.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE